Neuroleptic malignant syndrome with haloperidol and quetiapine treatment in a schizophrenia patient: A case report and 1 year follow up

dc.contributor.authorKarayilan, F. Alioglu
dc.contributor.authorYildiz, B.
dc.contributor.authorAk, I.
dc.date.accessioned2024-09-29T16:05:11Z
dc.date.available2024-09-29T16:05:11Z
dc.date.issued2023
dc.departmentKarabük Üniversitesien_US
dc.description31st European Congress of Psychiatry -- MAR 25-28, 2023 -- Paris, FRANCEen_US
dc.description.abstract[No abstract available]en_US
dc.identifier.doi10.1192/j.eurpsy.2023.2133
dc.identifier.endpageS1005en_US
dc.identifier.issn0924-9338
dc.identifier.issn1778-3585
dc.identifier.startpageS1005en_US
dc.identifier.urihttps://doi.org/10.1192/j.eurpsy.2023.2133
dc.identifier.urihttps://hdl.handle.net/20.500.14619/6555
dc.identifier.volume66en_US
dc.identifier.wosWOS:001060676603040en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherCambridge Univ Pressen_US
dc.relation.ispartofEuropean Psychiatryen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleNeuroleptic malignant syndrome with haloperidol and quetiapine treatment in a schizophrenia patient: A case report and 1 year follow upen_US
dc.typeConference Objecten_US

Dosyalar